| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Julie Langan, Daniel Martin, Polash Shajahan, Daniel J Smit. Antipsychotic dose escalation as a trigger for neuroleptic malignant syndrome (NMS): literature review and case series report. BMC psychiatry. vol 12. 2013-10-29. PMID:23194104. |
"neuroleptic malignant syndrome" (nms) is a potentially fatal idiosyncratic reaction to any medication which affects the central dopaminergic system. |
2013-10-29 |
2023-08-12 |
Not clear |
| Bichitra Nanda Patra, Sudhir K Khandelwal, Mamta Soo. Olanzapine induced neuroleptic malignant syndrome. Indian journal of pharmacology. vol 45. issue 1. 2013-09-26. PMID:23543750. |
an 18 year old male diagnosed as a case of bipolar affective disorder (bpad), developed neuroleptic malignant syndrome (nms) following treatment with olanzapine (20 mg per day), an atypical antipsychotic drug. |
2013-09-26 |
2023-08-12 |
Not clear |
| A Ahmad, C A Harrison, H G Davie. Two unusual complications of neuroleptic malignant syndrome. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine. vol 17. issue 2. 2013-08-28. PMID:23983420. |
neuroleptic malignant syndrome (nms) is a rare but well described complication of the administration of antipsychotic agents. |
2013-08-28 |
2023-08-12 |
Not clear |
| Brian D Berma. Neuroleptic malignant syndrome: a review for neurohospitalists. The Neurohospitalist. vol 1. issue 1. 2013-08-28. PMID:23983836. |
neuroleptic malignant syndrome (nms) is a life-threatening idiosyncratic reaction to antipsychotic drugs characterized by fever, altered mental status, muscle rigidity, and autonomic dysfunction. |
2013-08-28 |
2023-08-12 |
Not clear |
| Chin-Kuo Chang, Simon Harrison, William Lee, David Taylor, Robert Stewar. Ascertaining instances of neuroleptic malignant syndrome in a secondary mental healthcare electronic medical records database: the SLAM BRC Case Register. Therapeutic advances in psychopharmacology. vol 2. issue 2. 2013-08-28. PMID:23983959. |
neuroleptic malignant syndrome (nms) is a rare but potentially fatal complication of antipsychotic treatment. |
2013-08-28 |
2023-08-12 |
Not clear |
| Osamu Baba, Kenji Yamagata, Yasushi Tomidokoro, Akira Tamaoka, Hiroyuki Itoh, Toru Yanagawa, Kojiro Onizawa, Hiroki Bukaw. Neuroleptic malignant syndrome in a patient with tongue cancer: a report of a rare case. Case reports in dentistry. vol 2013. 2013-07-15. PMID:23853728. |
neuroleptic malignant syndrome (nms) is a rare but life-threatening complication of neuroleptic drugs, which are used widely in head and neck cancer (hanc) patients who develop delirium. |
2013-07-15 |
2023-08-12 |
Not clear |
| Koichi Nisijima, Katutoshi Shiod. Temporal changes in serum creatine kinase concentration and degree of muscle rigidity in 24 patients with neuroleptic malignant syndrome. Neuropsychiatric disease and treatment. vol 9. 2013-07-03. PMID:23818785. |
neuroleptic malignant syndrome (nms) is a dangerous adverse response to antipsychotic drugs. |
2013-07-03 |
2023-08-12 |
Not clear |
| Ernesto José Verdura Vizcaíno, Daniel Ballesteros Sanz, Javier Sanz-Fuentenebr. Electroconvulsive therapy as treatment for malignant neuroleptic syndrome. Revista de psiquiatria y salud mental. vol 4. issue 3. 2013-04-11. PMID:23446196. |
in the era of new antipsychotic drugs the severe symptomatology known by the name of neuroleptic malignant syndrome (nms) continues to have a high incidence and mortality. |
2013-04-11 |
2023-08-12 |
Not clear |
| Shrividya Chellam, Dhanwanti S Rajwade, Snehlata O Tavr. Emergency anaesthetic management of a severely anaemic, chronic schizophrenic patient with history of neuroleptic malignant syndrome. Indian journal of anaesthesia. vol 55. issue 6. 2013-03-17. PMID:22223911. |
neuroleptic agents are highly effective drugs used for the treatment of psychiatric disorders, but are rarely associated with neuroleptic malignant syndrome (nms). |
2013-03-17 |
2023-08-12 |
Not clear |
| Ikuko Kishida, Taku Furuno, Chiaki Kawanish. [Neuroleptic malignant syndrome (NMS)]. Nihon rinsho. Japanese journal of clinical medicine. vol 70 Suppl 6. 2013-03-05. PMID:23156583. |
[neuroleptic malignant syndrome (nms)]. |
2013-03-05 |
2023-08-12 |
Not clear |
| Federica Luchini, Lorenzo Lattanzi, Natalia Bartolommei, Luca Cosentino, Antonella Litta, Christine Kansky, Mauro Mauri, Giovanni Battista Cassano, Andrea Fagiolini, Francesco Casamassim. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports. The Journal of nervous and mental disease. vol 201. issue 1. 2013-02-28. PMID:23274293. |
we present the history of four bipolar patients who developed neuroleptic malignant syndrome (nms) after antipsychotic treatment, focusing on the relationship between nms and catatonia. |
2013-02-28 |
2023-08-12 |
Not clear |
| René Ernst Nielsen, Signe Olrik Wallenstein Jensen, Jimmi Nielse. Neuroleptic malignant syndrome-an 11-year longitudinal case-control study. Canadian journal of psychiatry. Revue canadienne de psychiatrie. vol 57. issue 8. 2013-02-26. PMID:22854034. |
to describe patients with neuroleptic malignant syndrome (nms), to establish occurrence of nms, to investigate risk factors of nms, and to investigate mortality associated with nms. |
2013-02-26 |
2023-08-12 |
Not clear |
| Reshma P Ambulkar, Vijaya P Patil, Aliasgar V Moiyad. Neuroleptic malignant syndrome: A diagnostic challenge. Journal of anaesthesiology, clinical pharmacology. vol 28. issue 4. 2012-12-12. PMID:23225938. |
she was diagnosed as neuroleptic malignant syndrome (nms) and the causative drug was carbamazepine. |
2012-12-12 |
2023-08-12 |
Not clear |
| Tarun Bhalla, Douglas Maxey, Amod Sawardekar, Joseph D Tobia. Anesthetic management of a pediatric patient with neuroleptic malignant syndrome. Journal of anesthesia. vol 26. issue 2. 2012-11-07. PMID:22101771. |
neuroleptic malignant syndrome (nms) is a rare disorder which is clinically similar to malignant hyperthermia (mh). |
2012-11-07 |
2023-08-12 |
Not clear |
| Federica Luchini, Lorenzo Lattanzi, Natalia Bartolommei, Luca Cosentino, Francesco Casamassima, Antonella Litta, Mauro Mauri, Giovanni Battista Cassan. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports]. Rivista di psichiatria. vol 47. issue 2. 2012-10-31. PMID:22622253. |
the authors present the cases of three bipolar patients who developed neuroleptic malignant syndrome (nms) after antipsychotic treatment, both typical and atypical, focusing on relationship between nms and catatonia. |
2012-10-31 |
2023-08-12 |
Not clear |
| P Kreuzer, M Landgrebe, M Wittmann, G Hajak, M Schecklmann, T B Poeppl, B Langgut. [Hypothermia under olanzapine treatment: clinical case series and review of current literature]. Der Nervenarzt. vol 83. issue 5. 2012-10-19. PMID:21626387. |
in clinical practice, much attention is paid to antipsychotic drug-induced elevation of body core temperature as observed in the neuroleptic malignant syndrome (nms). |
2012-10-19 |
2023-08-12 |
human |
| D R McLean, M S Hafez, R R Duarte-Afara, M E Obei. Four cases of neuroleptic malignant syndrome. Annals of Saudi medicine. vol 12. issue 1. 2012-10-02. PMID:17589122. |
the neuroleptic malignant syndrome (nms) is a relatively uncommon, sometimes fatal, idiosyncratic drug reaction usually associated with the administration of neuroleptic drugs. |
2012-10-02 |
2023-08-12 |
Not clear |
| B T Carrol. The universal field hypothesis of catatonia and neuroleptic malignant syndrome. CNS spectrums. vol 5. issue 7. 2012-10-02. PMID:18197153. |
catatonia and neuroleptic malignant syndrome (nms) are uncommon disorders that can be life-threatening. |
2012-10-02 |
2023-08-12 |
human |
| A Francis, S Chandragiri, S Rizvi, M Koch, G Petride. Is Lorazepam a treatment for neuroleptic malignant syndrome? CNS spectrums. vol 5. issue 7. 2012-10-02. PMID:18197156. |
the authors assessed the ability of lorazepam and other benzodiazepines to affect the course of neuroleptic malignant syndrome (nms). |
2012-10-02 |
2023-08-12 |
Not clear |
| D A White, A H Robin. An analysis of 17 catatonic patients diagnosed with neuroleptic malignant syndrome. CNS spectrums. vol 5. issue 7. 2012-10-02. PMID:18197157. |
this study was conducted to show that catatonia is a predisposing factor for neuroleptic malignant syndrome (nms) and to review the nosological relationship between catatonia and nms. |
2012-10-02 |
2023-08-12 |
Not clear |